Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

Houston Texans free agent and veteran wide receiver Stefon Diggs remains on the open market in the second week of free agency ...

The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.

The Philadelphia Eagles could look to add a veteran safety prior to the NFL Draft after cutting ties with C.J.

That said, Mason still managed to get his point across, especially when it came to how he was approaching his opportunity ...

New MIT Sloan research suggests that AI is more likely to complement, not replace, human workers. New research from the MIT ...